BlueFan Medical intends to invest an additional 2.45 billion plus yards of protective gloves during the year four expansion of production is expected to increase the built capacity by more than three times

On the evening of December 4th, BlueFan Medical announced that its subsidiary, Shandong BlueFan Health Technology Co., Ltd., intends to invest 2.45 billion yuan to invest in the construction capacity of 20 billion high-end health protection dingo gloves project in Linyi, Shandong Province.
reporter noted that this is the fourth time in the year that BlueFan Medical disclosed the expansion plan, if the construction of this expansion project is completed, BlueFan Medical's annual production capacity of health protection gloves will reach 80 billion units, an increase of 3.4 times over the end of 2019.
it is worth mentioning that while the health protection gloves business continues to expand production, BlueFan Medical's new main business heart stent business is also developing rapidly.
the acquisition in 2018, BlueFan Medical's cardiac intervention devices have grown at a high rate and are highly regarded by the industry.
2019, cardiac intervention device revenue reached 1,737 million yuan, up 71.55 percent year-on-year, accounting for nearly 50 percent of the company's total revenue, almost the same as the original health glove protection industry.
of this year, cardiac intervention device revenue decreased as it beed more difficult to go out for medical treatment and heart stent surgery decreased.
, However, China Pacific Securities pointed out in the report, with the restoration of medical order, the third quarter blue sail medical stent sales began to rebound.
will increase its production capacity by 3.4 times as much as BlueFan Medical announced its fourth capacity expansion plan for the year.
4, BlueFan Medical announced that its subsidiary Shandong BlueFan Health Technology Co., Ltd. intends to invest in the construction of an annual output of 20 billion high-end health protection dingo gloves project in Linyi, Shandong Province.
, BlueFan Medical said the company plans to invest 2.45 billion yuan in the expansion project.
, it is expected that the expansion project will be built in three phases, the total construction cycle was initially determined to be three years.
reporters note that this is not the first time this year blue sail medical proposed health gloves expansion plan.
is the world's largest one-time PVC glove manufacturer, with nearly 70% of its revenue coming from overseas markets.
, butyl gloves, PVC gloves are the two main products of Blue Sail Medical.
In recent years, due to the protective performance, stretch strength and hand comfort of butyl gloves, it has become the fastest growing high-end variety in the category of medical and protective gloves, and has also become the key development direction of blue sail medical treatment.
In August 2019, BlueFan Medical raised funds through a public offering of convertible bonds and plans to use 600 million yuan to raise funds for the construction of 4 billion PVC health protection gloves and the third phase of the 2 billion annual health protection (new gloves) project.
last October, BlueFan Medical used its own funds to start the construction of 4 billion PVC health protection gloves ahead of schedule.
February, under pressure from a surge in demand for medical protective equipment, BlueFan Medical launched the third phase of the Health Protection (New Gloves) program and announced an increase in the construction of an annual production of 2 billion PVC health protection gloves.
, Blue Sail Medical announced in the first half of the year "60 million pairs / year surgical gloves project", the use of the original site to add "1.25 billion / year TPE protective gloves" project and "30 billion / year health protection (dingo) gloves project."
by the Yangtze River Business Daily reporter incomplete statistics, as of this expansion project mentioned, Blue Fan Medical has announced the expansion of production four times in the year.
2019, Bluefing Medical's annual production capacity of 18 billion protective gloves, according to health data.
The total medical and protective glove production capacity of BlueFan Medical will reach 80 billion units/year after the completion of this expansion, which will be 3.44 times higher than before.
Lanfan Medical believes that from the current market supply and demand situation held by the company, even if the above-mentioned projects are completed and put into operation, it is still far from enough to meet the global market for protective gloves products continued strong demand.
double main industry supports high-speed growth, but with the completion of the acquisition of heart stent assets in recent years, BlueFan Medical gradually from the "glove king" to health protection and medical device dual main industry transformation.
2016, BlueFan Medical proposed an "A-X" transformation strategy.
expand from a single product to a holistic solution for the health protection family, while entering the field of high-value consumables.
2018, BlueFan Medical acquired Persein International for nearly $5.9 billion.
understand that Parsons International is the world's leading cardiovascular medical device enterprises.
, BlueFan Medical's revenue growth and revenue ratio from cardiac intervention devices such as heart stents have increased rapidly.
data show that in 2018-2019, cardiac intervention devices brought in revenue of 1.013 billion yuan and 1.737 billion yuan, respectively, with annual revenue growth of 71.55 percent.
same time, the share of cardiac intervention device revenue in total revenue increased from 38.17 percent to 49.99 percent.
same period last year, revenue from health protection gloves was RMB1,599 million and RMB1,678 million, respectively, an increase of 5.15% and 4.95 percent year-on-year, respectively.
in the development of both major industries are good circumstances, Blue Sail Medical's operating performance is also continuing to be good.
2018 and 2019, Lanfan Medical's operating income and net profit were RMB2,653 million and RMB3,476 million, respectively, up 68.35 percent and 31.00 percent year-on-year.
first half of this year, blue sail medical cardiac interventional device revenue fell nearly 40% year-on-year due to the impact of out-of-home medical treatment and reduced heart stent surgery.
, however, due to the global imbalance between supply and demand for health protection gloves, resulting in higher glove prices, for blue sail medical performance brought a larger increase.
same period last year, Blue Sail Medical's health protection gloves brought in revenue of 1.579 billion yuan, an increase of 97.4% year-on-year.
affected by this, blue sail medical revenue and net profit reached 4,655 million yuan and 1,888 million yuan, respectively, as of the third quarter, an increase of 79.14 percent and 403.16 percent year-on-year, respectively.
to this, China-Thai Securities Research Report pointed out that the company's cardiovascular business in the first three quarters by the domestic and foreign outbreaks continue to negatively affect, since the third quarter, the domestic market medical order gradually restored, is expected to start to rebound in stent sales.
the future with drug balloons, heart valves and other heavy new products on the market, the company has long-term sustained growth.
。